SCHEMBL21865558

SCHEMBL21865558

CCN(CCN(C(=O)OC(C)(C)C)c1cc(Cl)ccc1C(=O)OC)C(=O)OC(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.40
AHCY P23526 1/20 0.40
POLB P06746 2/20 0.38
MCOLN3 Q8TDD5 1/20 0.38
ALDH1A1 P00352 3/20 0.37
NR4A2 P43354 2/20 0.37
KDM4E B2RXH2 2/20 0.36
GLA P06280 2/20 0.36
GAA P10253 1/20 0.36
CYP3A4 P08684 2/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
RXFP1 Q9HBX9 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21865570 0.89 AHCY (0.40) AHCYMCOLN3ALDH1A1KDM4EGAA
SCHEMBL29835191 0.89 ABL1 (0.46) ABL1POLBMCOLN3ALDH1A1NR4A2
SCHEMBL21865383 0.84 AHCY (0.41) AHCYALDH1A1CYP3A4MEN1KMT2A
SCHEMBL21865632 0.83 PSEN1 (0.45) AHCY
SCHEMBL21865385 0.83 AHCY (0.40) ABL1AHCYALDH1A1CYP3A4SMN1; SMN2
SCHEMBL3532872 0.83 MAPT (0.41) ABL1POLBMCOLN3ALDH1A1NR4A2
SCHEMBL21865761 0.82 AHCY (0.40) AHCYALDH1A1GLACYP3A4HTT
SCHEMBL21865562 0.80 ALDH1A1 (0.41) ABL1AHCYPOLBALDH1A1KDM4E
SCHEMBL21865760 0.80 AHCY (0.39) AHCYALDH1A1KDM4EGAAMEN1
SCHEMBL28371791 0.77 CYP3A4 (0.44) MCOLN3ALDH1A1KDM4EGAACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020052509-A1 SULFONAMIDE COMPOUND SERVING AS SODIUM CHANNEL BLOCKER AND USES THEREOF 成都康弘药业集团股份有限公司 2020-03-19 WO disclosed